EX-21.1 3 fbio-20231231xex21d1.htm EX-21.1

EXHIBIT 21.1

​

SUBSIDIARIES OF FORTRESS BIOTECH, INC.

​

Subsidiaries of Fortress Biotech, Inc. at December 31, 2023, with jurisdiction of incorporation or formation:

​

| ● | Aevitas Therapeutics, Inc. (Delaware)

| ● | Avenue Therapeutics, Inc. (Delaware)

| ● | Cellvation, Inc. (Delaware)

| ● | Checkpoint Therapeutics, Inc. (Delaware)

| ● | Cyprium Therapeutics, Inc. (Delaware)

| ● | Helocyte, Inc. (Delaware)

| ● | Journey Medical Corporation (Delaware)

| ● | Mustang Bio, Inc. (Delaware)

| ● | Oncogenuity, Inc. (Delaware)

| ● | Urica Therapeutics, Inc. (Delaware)